Heart Failure With Reduced Ejection Fraction trials recruiting in Michigan

All Heart Failure With Reduced Ejection Fraction trials nationally

Cities in Michigan

Recruiting trials in Michigan

• A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
  NCT07214376 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · Michigan: Detroit
• Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score
  NCT07490067 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
  NCT06736574 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Michigan: Detroit